文献速递产科母胎医学

遗传性易栓症与复发性妊娠丢失的系统综述与荟萃分析

Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis.
PubMed 文献 · Hum Reprod · 2021-01-01

结果显示,携带FVL G1691A突变、凝血酶原基因G20210A突变或蛋白S缺乏的孕妇RPL风险升高,而抗凝血酶或蛋白C缺乏与RPL未见显著关联。

要点

  • FVL突变者RPL风险升高(OR 2.44,95%CI 1.96-3.03)。
  • 凝血酶原基因突变者RPL风险升高(OR 2.08,95%CI 1.61-2.68)。
  • 蛋白S缺乏者RPL风险升高(OR 3.45,95%CI 1.15-10.35)。

核心结论

  • 遗传性易栓症与复发性妊娠丢失风险升高存在可能关联,建议对RPL个体考虑进行遗传性易栓症检测。

主要发现

  • FVL突变者RPL风险升高(OR 2.44,95%CI 1.96-3.03)。
  • 凝血酶原基因突变者RPL风险升高(OR 2.08,95%CI 1.61-2.68)。
  • 蛋白S缺乏者RPL风险升高(OR 3.45,95%CI 1.15-10.35)。
  • 抗凝血酶缺乏或蛋白C缺乏与RPL未见显著关联(均P>0.05)。

关键数值与推荐

  • 暴露因素包括FVL突变、凝血酶原基因突变、抗凝血酶缺乏、蛋白C缺乏和蛋白S缺乏。
  • 采用随机效应模型合并总体风险估计,并进行亚组和敏感性分析。

临床怎么用

  • 对复发性妊娠丢失个体应考虑检测遗传性易栓症,尤其是FVL、凝血酶原基因突变和蛋白S缺乏。

局限性

  • 仅39项研究对一种或多种混杂因素进行了控制,所有纳入研究间异质性高。
  • 基于现有数据无法确定该关联是否受其他潜在RPL危险因素混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there an association between hereditary thrombophilia in pregnant women and risk of recurrent pregnancy loss (RPL)? SUMMARY ANSWER: Pregnant women with hereditary thrombophilia have an increased risk of RPL, especially for pregnant women with the G1691A mutation of the factor V Leiden (FVL) gene, the G20210A mutation of the prothrombin gene (PGM), and deficiency of protein S (PS). WHAT IS KNOWN ALREADY: Prior studies have suggested that pregnant women with hereditary thrombophilia have a higher risk of RPL, however, the results are inconsistent; furthermore, a complete overview is missing. This lack of information is an obstacle to the risk assessment of RPL in pregnant women with hereditary thrombophilia. A comprehensive meta-analysis on the relation between hereditary thrombophilia and the risk of RPL is needed. STUDY DESIGN, SIZE, DURATION: A systematic review and meta-analysis was performed using observational studies published in English before 1 April 2020 to evaluate the relation between hereditary thrombophilia and risk of RPL. PARTICIPANTS/MATERIALS, SETTING, METHODS: Relevant studies were identified from PubMed, Web of Science, and EMBASE searches and complemented with perusal of bibliographies of retrieved articles. The exposure of interest was hereditary thrombophilia, including FVL mutation, PGM, deficiency of antithrombin (AT), deficiency of protein C (PC), and deficiency of PS. The overall risk estimates were pooled using random effects models. Subgroup and sensitivity analyses were carried out to explore possible sources of heterogeneity and assess the robustness of the results. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 89 studies involving 30 254 individuals were included. Results showed that women with FVL mutation (odds ratio (OR): 2.44, 95% CI: 1.96-3.03), PGM (OR: 2.08, 95% CI: 1.61-2.68), or deficiency of PS (OR: 3.45, 95% CI: 1.15-10.35) had higher risks of developing RPL. Compared with the reference group, there was no observed relation between a deficiency in AT or PC and RPL (all P > 0.05). Heterogeneity in the risk estimates of RPL was partially explained by geographic region, definitions of RPL, types of RPL, and controlled confounders. Sensitivity analyses validated the robustness of the findings. LIMITATIONS, REASONS FOR CAUTION: Only 39 of the included studies controlled for one or more confounders, and the heterogeneity across all included studies was high. Based on the data available, we cannot determine whether this association is confounded by other potential risk factors of RPL. WIDER IMPLICATIONS OF THE FINDINGS: This systematic review and meta-analysis show a possible association between hereditary thrombophilia and an increased risk of RPL, suggesting that testing for hereditary thrombophilia should be considered in individuals with RPL. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the Hunan Provincial Key Research and Development Program (Grant number: 2018SK2062) and National Natural Science Foundation Program (Grant number: 81973137). There are no conflicts of interest. REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Liu X, Chen Y, Ye C, et al. Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod. 2021. PMID: 33575779. doi:10.1093/humrep/deab010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。